Numinus Wellness, Inc.

  • Market Cap: Micro Cap
  • Industry: Medical/Nursing Services
  • ISIN: CA67054W1032
CAD
0.05
0.01 (42.86%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

989.75 k

Shareholding (May 2024)

FII

0.90%

Held by 5 FIIs

DII

99.1%

Held by 0 DIIs

Promoter

0.00%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

Flat results in May 24

  • ROCE(HY) Lowest at -182.88%
  • DEBT-EQUITY RATIO (HY) Highest at 72.88 %
  • RAW MATERIAL COST(Y) Grown by 46.76% (YoY)
2

Risky - Not traded in last 10 days

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Medical/Nursing Services

stock-summary
Market cap

CAD 16 Million (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.19

stock-summary
Return on Equity

-466.08%

stock-summary
Price to Book

3.48

Revenue and Profits:
Net Sales:
4 Million
(Quarterly Results - May 2024)
Net Profit:
-5 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
66.67%
0%
66.67%
6 Months
11.11%
0%
11.11%
1 Year
-65.52%
0%
-65.52%
2 Years
-81.48%
0%
-81.48%
3 Years
-91.8%
0%
-91.8%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Numinus Wellness, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
86.33%
EBIT Growth (5y)
-278.40%
EBIT to Interest (avg)
-16.87
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.19
Sales to Capital Employed (avg)
1.03
Tax Ratio
0.19%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
3.48
EV to EBIT
-0.79
EV to EBITDA
-0.90
EV to Capital Employed
4.07
EV to Sales
0.71
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-514.97%
ROE (Latest)
-466.08%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
Bullish
No Signal
Bollinger Bands
Mildly Bullish
Sideways
Moving Averages
Bearish (Daily)
KST
Bearish
Dow Theory
No Trend
No Trend
OBV
Mildly Bearish
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : May 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 5 Foreign Institutions (0.9%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - May'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended May 2024 is -14.00% vs -15.25% in Feb 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended May 2024 is 15.00% vs -36.36% in Feb 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "May'24",
        "Feb'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "4.30",
          "val2": "5.00",
          "chgp": "-14.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-3.50",
          "val2": "-4.40",
          "chgp": "20.45%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.10",
          "val2": "0.20",
          "chgp": "-50.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-0.70",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-5.10",
          "val2": "-6.00",
          "chgp": "15.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-909.70%",
          "val2": "-1,002.80%",
          "chgp": "9.31%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Aug'23",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Aug 2023 is 256.92% vs 333.33% in Aug 2022",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Aug 2023 is 32.52% vs -138.83% in Aug 2022",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Aug'23",
        "Aug'22",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "23.20",
          "val2": "6.50",
          "chgp": "256.92%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-24.10",
          "val2": "-26.90",
          "chgp": "10.41%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.80",
          "val2": "0.60",
          "chgp": "33.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-2.00",
          "val2": "-16.10",
          "chgp": "87.58%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-30.30",
          "val2": "-44.90",
          "chgp": "32.52%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-1,163.00%",
          "val2": "-4,381.00%",
          "chgp": "321.80%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - May'24 - QoQstock-summary
May'24
Feb'24
Change(%)
Net Sales
4.30
5.00
-14.00%
Operating Profit (PBDIT) excl Other Income
-3.50
-4.40
20.45%
Interest
0.10
0.20
-50.00%
Exceptional Items
0.00
-0.70
100.00%
Consolidate Net Profit
-5.10
-6.00
15.00%
Operating Profit Margin (Excl OI)
-909.70%
-1,002.80%
9.31%
USD in Million.
Direction Arrows
Net Sales

QoQ Growth in quarter ended May 2024 is -14.00% vs -15.25% in Feb 2024

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended May 2024 is 15.00% vs -36.36% in Feb 2024

Annual Results Snapshot (Consolidated) - Aug'23stock-summary
Aug'23
Aug'22
Change(%)
Net Sales
23.20
6.50
256.92%
Operating Profit (PBDIT) excl Other Income
-24.10
-26.90
10.41%
Interest
0.80
0.60
33.33%
Exceptional Items
-2.00
-16.10
87.58%
Consolidate Net Profit
-30.30
-44.90
32.52%
Operating Profit Margin (Excl OI)
-1,163.00%
-4,381.00%
321.80%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Aug 2023 is 256.92% vs 333.33% in Aug 2022

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Aug 2023 is 32.52% vs -138.83% in Aug 2022

stock-summaryCompany CV
About Numinus Wellness, Inc. stock-summary
stock-summary
Numinus Wellness, Inc.
Medical/Nursing Services
Numinus Wellness Inc. (Numinus) is a Canada-based health care company focused on creating an ecosystem of wellness solutions through access, research, training and therapies centered on psychedelic therapies. The Company, through its subsidiary Salvation Botanicals Ltd, has a Health Canada cannabis testing license and dealer’s license. The testing license allows the Company to test and analyze cannabis products from licensed producers, and the dealer’s license allows the Company to test, possess, buy and sell methylenedioxymethamphetamine (MDMA), psilocybin, psilocin, dimethyltryptamine (DMT) and mescaline. Numinus also operates a stand-alone center offering patients integrative health solutions.
Company Coordinates stock-summary
Company Details
1746 Macdonald St , VANCOUVER BC : V6K 3X8
stock-summary
Tel: 1 604 3292079
stock-summary
Registrar Details